Safety of omitting defibrillation efficacy testing with subcutaneous defibrillators: a propensity matched case-control study

Back

EHRA Premium Access

Safety of omitting defibrillation efficacy testing with subcutaneous defibrillators: a propensity matched case-control study

Session: News from ICD therapy

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor V. Bianchi (Naples, IT)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Doctor Valter Bianchi

AO dei Colli - Monaldi Hospital, Naples (Italy)

0 follower

7 more presentations in this session

Five year outcomes of the subcutaneous implantable cardioverter-defibrillator EFFORTLESS (evaluation of factors impacting clinical outcome and cost effectiveness of the S-ICD) registry

Speaker: Professor P. Lambiase (London, GB)

Accelerometry-assessed physical behaviour and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: a systematic review.

Speaker: Mr M. Kolk (Amsterdam, NL)

Subcutaneous and single-chamber transvenous defibrillators: a nationwide matched control study.

Speaker: Doctor A. Bodin (Tours, FR)

Prognostic impact of subcutaneous implantable cardioverter-defibrillator appropriate and inappropriate shocks

Speaker: Doctor L. Oliveira (Ponta Delgada, PT)

Serratus anterior plane block reduces perioperative sedation use and discharge analgesia in subcutaneous implantable defibrillator implantation

Speaker: Doctor A. Mistry (Leicester, GB)

Access the full session

News from ICD therapy

Speakers: Doctor V. Bianchi, Professor P. Lambiase, Mr M. Kolk, Doctor A. Bodin, Doctor L. Oliveira...

Access

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources